Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Amplitude Promesse SAS (AMPLI) EUR0.01

Sell:€1.58 Buy:€1.60 Change: €0.18 (12.86%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: €0.18 (12.86%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: €0.18 (12.86%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Amplitude Surgical SA is a France-based company engaged in the field of orthopedic surgeries. The Company offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. It operates through ofab Orthopedie, a strategic industrial subcontractor

Contact details

11, Cours Jacques Offenbach
+33 (4) 75418741

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€66.93 million
Shares in issue:
47.80 million
Health Care Equipment
Euronext Paris

Key personnel

  • Olivier Jallabert
    Chairman of the Board and Chief Executive Officer, Chairman of the Management Board, Founder
  • Muriel Benedetto Marmilloud
    Chief Operating Officer
  • Philippe Garcia
    Vice President - Finance, Member of the Management Board
  • Bruno Jugnet
    Vice President of Marketing, Member of the Management Board
  • Jean-Christophe Vial
    Vice President - International, Member of the Management Board
  • Laurent Geais
    Vice President - Research & Development, Member of the Management Board
  • Mireille Lemery
    Member of the Management Board, Director of US Regulatory Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.